Colgate Palmolive (CL) Operating Margin (2009 - 2026)
Colgate Palmolive (CL) posted Operating Margin of 18.95% for Q2 2026, up 4.67% on a QoQ basis from 18.11% in Q1 2026, and down 218.0% year-over-year from 16.06% in Q2 2025.
Analysis
Colgate Palmolive (CL) Operating Margin (2009 - 2026) Analysis & Trends
Colgate Palmolive has reported Operating Margin for 18 years, with the latest figure at 18.95% in Q2 2026.
- On a quarterly basis, Operating Margin fell 218.0% year-over-year to 18.95% in Q2 2026; TTM through Jun 2026 was 14.88%, a 654.0% decrease from a year earlier, with the FY2025 full-year figure at 16.22%, down 501.0% from the prior year.
- Operating Margin was 18.95% for Q2 2026 at Colgate Palmolive, up from 18.11% in the prior quarter.
- The five-year high for Operating Margin was 21.91% in Q1 2025, with the low at 1.76% in Q4 2025.
- Average Operating Margin over 5 years is 18.56%, with a median of 20.66% recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Operating Margin surged 1729 bps in 2023, then tumbled 1974 bps in 2025.
- Over 5 years, Operating Margin stood at 4.36% in 2022, then surged by 396 bps to 21.66% in 2023, then dropped by 1 bps to 21.5% in 2024, then tumbled by 92 bps to 1.76% in 2025, then soared by 977 bps to 18.95% in 2026.
- The last three Operating Margin figures came in at 18.95% (Q2 2026), 18.11% (Q1 2026), and 1.76% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.19 Bn | 68.82 Bn | 3.30 Bn | 18.95% |
| 2 | Kenvue | 34.67 Bn | 33.56 Bn | 2.30 Bn | 17.67% |
| 3 | Kimberly Clark | 33.45 Bn | 32.49 Bn | 1.60 Bn | 15.11% |
| 4 | Bath & Body Works | 3.95 Bn | 3.15 Bn | 692.00 Mn | 14.27% |
| 5 | Prestige Consumer Healthcare | 2.38 Bn | 2.31 Bn | - | - |
| 6 | Perrigo | 2.02 Bn | 1.62 Bn | 313.90 Mn | 2.30% |
| 7 | Herbalife | 1.27 Bn | 894.99 Mn | 1.03 Bn | 9.67% |
| 8 | Edgewell Personal Care | 1.26 Bn | 863.27 Mn | 242.50 Mn | 4.39% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 623.99 Mn | 518.09 Mn | 40.36 Mn | 11.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.95% |
| Mar 31, 2026 | 18.11% |
| Dec 31, 2025 | 1.76% |
| Sep 30, 2025 | 20.64% |
| Jun 30, 2025 | 21.14% |
| Mar 31, 2025 | 21.91% |
| Dec 31, 2024 | 21.50% |
| Sep 30, 2024 | 21.16% |
| Jun 30, 2024 | 21.59% |
| Mar 31, 2024 | 20.67% |
| Dec 31, 2023 | 21.66% |
| Sep 30, 2023 | 20.94% |
| Jun 30, 2023 | 20.20% |
| Mar 31, 2023 | 19.06% |
| Dec 31, 2022 | 4.36% |
| Sep 30, 2022 | 21.26% |
| Jun 30, 2022 | 19.71% |
| Mar 31, 2022 | 19.55% |
| Dec 31, 2021 | 8.29% |
| Sep 30, 2021 | 21.91% |